Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATITIA: LTA-Guided vs Standard Antiplatelet Therapy in Intracranial Stenting
NCT05825391Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2023
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin, clopidogrel and ticagrelor in intracranial aneurysm (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Ischemic events at 30 days. Started May 2023; status: completed.
02
Drugs
aspirinclopidogrelticagrelor
03
Conditions
intracranial aneurysm
Beyond the preview
Go deeper on NCT05825391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825391.